World Health Organization site
Skip Navigation Links
Home
Advanced Search
List ByExpand List By
Search Tips
UTNExpand UTN
ICTRP websiteExpand ICTRP website
Contact us
                   2182 records for 421 trials found!
Trials are sometimes recorded in more than one registry. These records can refer to each other using the 'Secondary ID' field. The search portal uses these Secondary IDs to group records about the same trial together in the search results.
Each group of records referring to a trial is displayed in table that is seen by pressing the + symbol. The record with the earliest date of registration is always shown first.
 
 
 
 
  Showrecords per page     

1 2 3 4 5 6 7 8 9 10 Last
Recruitment statusMain ID Public TitleDate of Registration
RecruitingNCT02856984
Zika in Infants and Pregnancy (ZIP)
20/07/2016
RecruitingNCT02812914
NACER II: Reducing Prenatal Exposures to Household Air Pollution in Rural Guatemala Through a Gas Stove/Behavior Intervention to Improve Neonatal Health
03/06/2016
AuthorisedEUCTR2015-004224-59-CZ
Sitagliptin add-on to Metformin up-titration Study
Recruitment statusMain IDPublic titleDate of registration
RecruitingNCT02791490A Study of the Safety and Efficacy of Sitagliptin Addition During Metformin Up-titration (MK-0431-848)01/06/2016
27/04/2016
Not recruitingNCT02748213
A Study of Trastuzumab (Herceptin) in Women With Human Epidermal Growth Factor Receptor (HER) 2-Positive Advanced and/or Metastatic Breast Cancer
20/04/2016
RecruitingNCT02720081
Study of MK-1029 in Participants With Persistent Asthma That Cannot Be Controlled With Montelukast (MK-1029-015)
Recruitment statusMain IDPublic titleDate of registration
AuthorisedEUCTR2015-005054-36-PLPhase-II Study of MK-1029 added to Montelukast in Adults with Uncontrolled Asthma.11/07/2016
22/03/2016
AuthorisedEUCTR2009-010110-30-HU
The effect and long-term safety of MK-0887A in children with asthma 29/02/2016
RecruitingNCT02714595
Study of S-649266 or Best Available Therapy for the Treatment of Severe Infections Caused by Carbapenem-resistant Gram-negative Pathogens 26/02/2016
AuthorisedEUCTR2015-004326-34-SE
Trial 2 to Assess MK-8342B Treatment Efficacy-Safety in Dysmenorrhea
Recruitment statusMain IDPublic titleDate of registration
AuthorisedEUCTR2015-004326-34-PLTrial to Assess MK-8342B Treatment Efficacy-Safety in Dysmenorrhea25/01/2016
Not recruitingNCT02668822Efficacy and Safety of Etonogestrel + 17ß-Estradiol Vaginal Ring in Treatment of Women With Primary Dysmenorrhea (MK-8342B-060)26/01/2016
08/12/2015
RecruitingNCT02826603
Study of Secukinumab Compared to Ustekinumab in Subjects With Plaque Psoriasis
Recruitment statusMain IDPublic titleDate of registration
AuthorisedEUCTR2015-002898-37-HUStudy of efficacy and safety of secukinumab compared to ustekinumab in subjects with plaque psoriasis30/03/2016
30/11/2015
Not recruitingNCT02576275
A Study of Duvelisib in Combination With Rituximab and Bendamustine vs Placebo in Combination With Rituximab and Bendamustine in Subjects With Previously-Treated Indolent Non-Hodgkin Lymphoma (BRAVURA)
Recruitment statusMain IDPublic titleDate of registration
Not RecruitingEUCTR2015-004033-28-HUA clinical trial which compares the safety and efficacy of chemotherapy (Rituximab and Bendamustine ) combined with Duvelisib, the study treatment, or a placebo in patients who have previously treated Indolent Non-Hodgkin Lymphoma. 19/01/2016
Not RecruitingEUCTR2015-004033-28-PTA clinical trial which compares the safety and efficacy of chemotherapy (Rituximab and Bendamustine ) combined with Duvelisib, the study treatment, or a placebo in patients who have previously treated Indolent Non-Hodgkin Lymphoma. 11/04/2016
Not RecruitingEUCTR2015-004033-28-ATA clinical trial which compares the safety and efficacy of chemotherapy (Rituximab and Bendamustine ) combined with Duvelisib, the study treatment, or a placebo in patients who have previously treated Indolent Non-Hodgkin Lymphoma. 15/04/2016
Not RecruitingEUCTR2015-004033-28-EEA clinical trial which compares the safety and efficacy of chemotherapy (Rituximab and Bendamustine ) combined with Duvelisib, the study treatment, or a placebo in patients who have previously treated Indolent Non-Hodgkin Lymphoma. 10/05/2016
Not RecruitingEUCTR2015-004033-28-PLA clinical trial which compares the safety and efficacy of chemotherapy (Rituximab and Bendamustine ) combined with Duvelisib, the study treatment, or a placebo in patients who have previously treated Indolent Non-Hodgkin Lymphoma. 19/04/2016
Not RecruitingEUCTR2015-004033-28-DEA clinical trial which compares the safety and efficacy of chemotherapy (Rituximab and Bendamustine ) combined with Duvelisib, the study treatment, or a placebo in patients who have previously treated Indolent Non-Hodgkin Lymphoma. 07/04/2016
Not RecruitingEUCTR2015-004033-28-FIA clinical trial which compares the safety and efficacy of chemotherapy (Rituximab and Bendamustine ) combined with Duvelisib, the study treatment, or a placebo in patients who have previously treated Indolent Non-Hodgkin Lymphoma. 31/03/2016
Not RecruitingEUCTR2015-004033-28-ESA clinical trial which compares the safety and efficacy of chemotherapy (Rituximab and Bendamustine ) combined with Duvelisib, the study treatment, or a placebo in patients who have previously treated Indolent Non-Hodgkin Lymphoma.20/04/2016
07/10/2015
    
1 2 3 4 5 6 7 8 9 10 Last
Disclaimer: Trials posted on this search portal are not endorsed by WHO, but are provided as a service to our users. In no event shall the World Health Organization be liable for any damages arising from the use of the information linked to in this section. None of the information obtained through use of the search portal should in any way be used in clinical care without consulting a physician or licensed health professional. WHO is not responsible for the accuracy, completeness and/or use made of the content displayed for any trial record.
Copyright - World Health Organization - Version 3.2 - Version history